URGN
UroGen Pharma·NASDAQ
--
--(--)
--
--(--)
3.09 / 10
Netural
Fundamental quality is subdued, rated Neutral with a 3.1/10 score. Key weaknesses include limited revenue growth (Total/Optering revenue YoY ~9.3%) and high days sales outstanding (75.06), which drag on liquidity. However, the interest-coverage ratio (15.48) and several asset-based metrics (Asset-MV, Profit-MV) provide balance. The mixed factor profile suggests a defensive positioning while awaiting operational improvement.
Analysis Checks(6/10)
Revenue-MV
Value-1.56
Score1/3
Weight8.92%
1M Return4.24%
Value-1.56
Score1/3
Weight8.92%
1M Return4.24%
Days sales outstanding
Value75.06
Score1/3
Weight-2.44%
1M Return-1.57%
Value75.06
Score1/3
Weight-2.44%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight17.74%
1M Return8.45%
Value-0.17
Score2/3
Weight17.74%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.77%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.77%
1M Return-1.11%
Asset-MV
Value-0.50
Score2/3
Weight22.85%
1M Return10.15%
Value-0.50
Score2/3
Weight22.85%
1M Return10.15%
Total operating revenue (YoY growth rate %)
Value9.29
Score1/3
Weight-1.30%
1M Return-0.79%
Value9.29
Score1/3
Weight-1.30%
1M Return-0.79%
Profit-MV
Value0.46
Score2/3
Weight17.72%
1M Return8.45%
Value0.46
Score2/3
Weight17.72%
1M Return8.45%
PB-ROE
Value3.93
Score2/3
Weight22.10%
1M Return9.14%
Value3.93
Score2/3
Weight22.10%
1M Return9.14%
Operating revenue (YoY growth rate %)
Value9.29
Score1/3
Weight-1.25%
1M Return-0.76%
Value9.29
Score1/3
Weight-1.25%
1M Return-0.76%
Cash-MV
Value-0.07
Score2/3
Weight17.42%
1M Return8.41%
Value-0.07
Score2/3
Weight17.42%
1M Return8.41%
Revenue-MV
Value-1.56
Score1/3
Weight8.92%
1M Return4.24%
Value-1.56
Score1/3
Weight8.92%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value9.29
Score1/3
Weight-1.30%
1M Return-0.79%
Value9.29
Score1/3
Weight-1.30%
1M Return-0.79%
Days sales outstanding
Value75.06
Score1/3
Weight-2.44%
1M Return-1.57%
Value75.06
Score1/3
Weight-2.44%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight17.72%
1M Return8.45%
Value0.46
Score2/3
Weight17.72%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight17.74%
1M Return8.45%
Value-0.17
Score2/3
Weight17.74%
1M Return8.45%
PB-ROE
Value3.93
Score2/3
Weight22.10%
1M Return9.14%
Value3.93
Score2/3
Weight22.10%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.77%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.77%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value9.29
Score1/3
Weight-1.25%
1M Return-0.76%
Value9.29
Score1/3
Weight-1.25%
1M Return-0.76%
Asset-MV
Value-0.50
Score2/3
Weight22.85%
1M Return10.15%
Value-0.50
Score2/3
Weight22.85%
1M Return10.15%
Cash-MV
Value-0.07
Score2/3
Weight17.42%
1M Return8.41%
Value-0.07
Score2/3
Weight17.42%
1M Return8.41%
Is URGN fundamentally strong?
- URGN scores 3.09/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, -170.59% net margin, -6.07 P/E ratio, -8.66 P/B ratio, and -23.49% earnings growth, these metrics solidify its Netural investment rating.
